Qual é o preço para LumiraDx Limited (LMDX)

O preço para LumiraDx Limited (LMDX) é $0.016

Qual é a capitalização de mercado para LumiraDx Limited (LMDX)

A capitalização de mercado para LumiraDx Limited (LMDX) é $5.10M

LumiraDx Limited (LMDX) LPA

LumiraDx Limited is a prominent provider of point-of-care diagnostic solutions. Its core mission is to revolutionize community healthcare by equipping medical professionals with crucial diagnostic insights directly at the patient's side. The company develops and commercializes a sophisticated diagnostic platform, offering a diverse array of tests that deliver laboratory-grade performance directly at the point of care. With approximately 30 tests either commercially available or under development, their comprehensive portfolio addresses critical conditions such as infectious diseases, cardiovascular disorders, diabetes, and coagulation issues. Furthermore, they offer a full suite of COVID-19 testing solutions, adaptable for both laboratory environments and immediate point-of-need applications. These diagnostic tools are widely adopted by governments and healthcare institutions, deployed in diverse settings including traditional laboratories, urgent care clinics, physician's offices, pharmacies, schools, and workplaces. Their applications span screening, diagnosis, and monitoring for both general wellness and specific diseases. Established in 2014, the company's headquarters are located in London, United Kingdom.

Ano	EPS	Alterar
Não há dados suficientes para as datas fornecidas.

Ano

EPS

Alterar

Não há dados suficientes para as datas fornecidas.

Empresa	EPS	Diferença de EPS	País
Thermo Fisher Scientific Inc. TMO.US	$18.62	-	US
Danaher Corporation DHR.US	$5.65	-	US
WuXi AppTec Co., Ltd. 603259.SS	-	-	CN
Natera, Inc. NTRA.US	$-1.36	-	US
IDEXX Laboratories, Inc. IDXX.US	$14.24	-	US

Empresa

EPS

Diferença de EPS

País